Intra-individual Cross-over Efficacy Evaluation of Dotarem-Enhanced MRI Compared to Gadovist/ Gadavist-Enhanced MRI in the Diagnosis of Brain Tumors

Trial Profile

Intra-individual Cross-over Efficacy Evaluation of Dotarem-Enhanced MRI Compared to Gadovist/ Gadavist-Enhanced MRI in the Diagnosis of Brain Tumors

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jan 2017

At a glance

  • Drugs Gadoterate-meglumine (Primary) ; Gadobutrol
  • Indications Brain cancer
  • Focus Diagnostic use
  • Acronyms REMIND
  • Sponsors Guerbet
  • Most Recent Events

    • 24 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 17 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top